Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06041906 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

International Registry of Congenital Portosystemic Shunt (IRCPSS)

Study acronym: IRCPSS
StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 28 to 26v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Congenital Portosystemic Shunt (CPSS) is a rare condition important by the multiplicity and severity of associated complications. CPSS is venous anomaly in which blood coming from the intestines only partially passes through the liver. This leads to the accumulation of potentially toxic factors that cause systemic effects. Complications vary among the individuals, and currently, it is challenging to predict which individuals will develop severe complications. The IRCPSS registry is established with the aim of centralizing detailed clinical follow-up and biological information from participants around the world who suffer from Congenital Portosystemic Shunt (CPSS). A multidisciplinary consortium of experts is collaborating to enhance our understanding of the prevalence, natural history, individual risks, and physiopathology of the disease through the IRCPSS registry.
Trial Details
NCT Number NCT06041906
Lead Sponsor Prof. Valérie Mc Lin
Collaborators: European Society of Pediatric Gastroenterology, Hepatology and Nutrition, European Association for the Study of the Liver (EASL), Fondation Andrea Ferrari
Conditions
(from sponsor)		 Congenital Portosystemic Shunt, CPSS (Congenital Portosystemic Shunt)
Related terms Congenital Portosystemic Shunt, Hepatic Encephalopathy, Hepatopulmonary Syndrome, Hyperammonemia, Hyperandrogenism, Hyperinsulinism, Hypertension, Pulmonary, Hypoglycemia, Insulin Resistance, Liver Neoplasms, Rare Diseases, Vascular Malformations
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov